MTEC is a public-private partnership that is authorized to serve by the Department of Defense to promote the development and delivery of innovative medical technologies to improve the health and safety of military personnel, veterans, and civilians.
Learn more in the 2023 Annual Report
Who We Are
The Medical Technology Enterprise Consortium is a 501(c)(3) biomedical technology consortium that is internationally-dispersed, collaborating with multiple government agencies under a 10-year renewable Other Transaction Agreement with the U.S. Army Medical Research and Development Command. The consortium focuses on the development of medical solutions that protect, treat, and optimize the health and performance of U.S. military personnel and civilians.
From the Chair
Ellen Embrey, MTEC Chair
The United States military medical corps ensures the health and welfare of our active duty service men and women. MTEC, in turn, works with our military medical sponsors to ensure that unmet military medical needs and potential solutions are identified and developed. As innovation ecosystems go, the synergy between military medicine, the Defense Health Agency (DHA), and MTEC advances health innovation for this most important population – our military. In turn, military families, communities and veterans benefit as we explore civilian applications of health innovation in parallel with military medical advances.
Special thanks to our professional staff who continue to be high performing, especially with communications and outreach to all of you. We hosted a record number of webinars, events, scouting and pitch competitions. Our team is building commercialization services, subject matter expert networks through our M-Corps Partners, and a growing portfolio of projects selected for funding by our sponsors.
We look forward to growing and learning with you in the years to come to keep our military medical enterprise healthier and stronger than ever.
Sincerely,
Ellen Embrey
MTEC Chair
MTEC Leadership
MTEC Board of Directors
Chair
Ellen Embrey's Bio
Roles & Responsibilities:
Chair
Bio:
Ms. Embrey is a seasoned senior executive with extensive DoD policy and program management experience in military health care, deployment medicine, biomedical research & technology development, and disaster preparedness planning and response. As the managing partner of Stratitia, she is a proven leader and change manager, known for her ability to develop and manage effective, high performing programs and teams, particularly within the DoD medical enterprise.
Small Business Representative
Christopher Hlubb's Bio
Roles & Responsibilities:
Small Business Representative
Bio:
Chief Executive Officer, Agrilogics Group
Chris began his career at Johns Hopkins Hospital in the fields of biochemical neurogenetics and neurophysiology contributing to the development of novel nutritional supplements to treat childhood metabolic disease and advanced surgical medical device applications. Chris’ global industrial, manufacturing, R&D and product development experience has aided private industry, academia, U.S. government, private investors and non-profits with a focus on rapid commercialization, government advocacy, investments and IP development. Chris has also developed strategic programming initiatives for non-profits to promote start-up commercialization, provide advisory services and mentorship as well as industry networking and has helped to raise over $150mm in private funding for global early-stage corporations.
Company Profile
Agrilogics Group Inc is the parent company of Lactea Therapeutics, LLC, Hyacinth Proteins, LLC and Agrilogics Animal Health, LLC.
The group was founded to develop platform technologies to advance industrial-scale pharmaceutical grade biopurification of innate immune proteins as a new class of preventative medicine for existing and emerging pathogen agnostic threats.
Academia/ Not-for-Profit Board Representative
Dr. Pierre Noel's Bio
Roles & Responsibilities:
Academia/ Not-for-Profit Board Representative
Bio:
Pierre Noel is Director of the Mayo Clinic’s Center for Military Medicine, which coordinates military-related practice, education, and research programs across the Mayo Clinic and provides medical services and education to active-duty service members and retirees. He is currently a physician in the Mayo Clinic’s Department of Internal Medicine Division of Hematology and Oncology, a Senior Visiting Fellow at the Brent Scowcroft Center on International Security, a Professor of Medicine at the Mayo Clinic College of Medicine and Science, and a primary consultant in protective medicine to the White House Medical Unit.
Since 2012, Dr. Noel has served as Director of Special Operations Tactical Medicine at the Mayo Clinic, a program specializing in combat trauma and critical care. In this role, he has trained more than 700 special operations personnel in prolonged field care and tactical combat casualty care. Previously, Dr. Noel was Chief of Hematology and a Senior Clinician at the National Institutes of Health Clinical Center, as well as a physician in military operations with the U.S. Air Force for more than 10 years, retiring with the rank of Lieutenant Colonel. Throughout his military and public service career, Dr. Noel has worked diligently to advance the health, safety, and effectiveness of the U.S. Armed Forces.
Large Business Representative
Dr. Andrew Omidvar's Bio
Roles & Responsibilities:
Large Business Representative
Bio:
Vice President of Enterprise and Government R&D, Philips Healthcare
Dr. Andrew Omidvar joined Philips as Vice President of Enterprise and Government R&D for Healthcare. He is responsible for shaping the long-term business strategy for Philips in the Federal Government Research & Development sector. Dr. Omidvar’s experience and network will be beneficial to MTEC as he can help guide and align strategies to the stakeholder’s mission and vision. He can also advance and guide innovations required for our service members to commercialization and bring industrial scale to military medical solutions. He has been instrumental in bridging gaps between requirements and R&D innovations to further support who needs them the most. Dr. Omidvar is a new addition to MTEC’s Board of Directors because he has a clear vision and path from what could be to what can be.
Company Profile
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries.
At Large Board Representative
Dr. Ron Poropatich's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
Dr. Ron Poropatich currently serves as the Director of the Center for Military Medicine Research (CMMR) and as a Professor of Medicine in the Pulmonary, Allergy and Critical Care Division at the University of Pittsburgh. Under Dr. Poropatich’s leadership, the CMMR has developed a large DoD medical research portfolio and established the University of Pittsburgh as a key collaborative research partner for the DoD. Since 2012, Dr. Poropatich has also acted as the Senior Advisor on Telemedicine for the University of Pittsburgh Medical Center, leveraging the use of virtual health solutions for this innovative leader in health care delivery.
With more than 30 years of clinical service in the military health care system, Dr. Poropatich understands deeply the importance of quality medical care for service members and veterans. Before retiring from the U.S. Army in August 2012 with the rank of Colonel, Dr. Poropatich served in many leadership positions at the Walter Reed National Military Medical Center and the U.S. Army Medical Research and Materiel Command Telemedicine and Advanced Technology Research Center. Even in retirement, Dr. Poropatich continues to serve the Nation as a board member of the VA Research Foundation for the Veterans Affairs Pittsburgh Healthcare System.
At Large Board Representative
Amy Salzhauer's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
Amy Salzhauer is a Founder and Managing Partner at Good Growth Capital, an early-stage venture fund based in Charleston, SC but investing across the country. Amy was previously the CEO of Ignition Ventures, where she and her team helped to transfer technologies ranging from chip-based fuel cells (Lilliputian Systems) and self-organizing networks (Ember Corporation) to black silicon (SiOnyx), selective brain cooling (Toev Medical), and the world’s most accurate scale (Bioscale) out of academic research labs.
Amy is an inventor who holds several patents and speaks and teaches internationally about entrepreneurship and leadership, has served on multiple boards, and has been featured on the covers of multiple business magazines. She currently serves on the Boards of Directors for Leuko Labs, the Roper St Francis Hospital Foundation, and Reading Partners of South Carolina.
Amy’s many recognitions include being selected by the World Economic Forum as one of its one hundred top “Global Leaders for Tomorrow,” and being chosen multiple times as a top “40 Under 40” business leader. Her previous experience includes writing about science, sports, and innovation for magazines like Newsweek, Science, Technology Review, and Harvard Business Review; researching radioactive mutant slime molds; stints as a management consultant and at the United Nations; drumming for the U.S. National Dragonboat Team (winning a silver medal at the 2003 World Championships); and serving as the Assistant Director of a non-profit environmental organization in Washington D.C. She holds an MBA from MIT; an M.Phil in Plant Sciences from Cambridge University where she was a Herschel Smith Harvard Scholar; and an A.B. magna cum laude from Harvard University.
At Large Board Representative
Peter Soderberg's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
With over 50 years of service in the healthcare industry, Mr. Soderberg currently is Managing Partner for Worthy Venture Resources LLC, which maintains active investments in, and serves on the boards of, several privately held medical device companies around the world. Further, since 2011 he has served as Chairman of the Board of Tactile Medical (NASDAQ: TCMD), a chronic disease management company. With his wife he also manages the Elsa and Peter Soderberg Charitable Foundation, which focuses on health initiatives for underserved women and children, and educational and economic empowering for the poor and underserved. Two of their catalytic philanthropy projects focus on affordable and adapted housing for wounded U.S. veterans.
Mr. Soderberg’s prior business experience includes 23 years at Johnson and Johnson, serving in the U.S. and overseas in a variety of operations, marketing, and management positions in four of J&J’s over the counter and professional products companies. From 1987 to 1993, he was President of Johnson & Johnson Health Management, a behavioral health company. From 1993-2006 he served as President and CEO at privately held Welch Allyn from 2000 onwards, preceded by service as Group Vice President and COO there. Welch Allyn was acknowledged by the DoD as a significant supplier/partner of patient monitoring systems during Operation Desert Storm and Desert Shield. In 2006 Peter joined Hillenbrand Industries (NYSE: HI) and its largest subsidiary, Hill-Rom, as President & CEO of both entities. In 2008 he separated the medical technology company from Hillenbrand. He continued to serve as President and CEO of Hill-Rom (NYSE: HRC) until 2010, when he entered semi-retirement.
Mr. Soderberg received his degree in Engineering and Applied Sciences (Magna Cum Laude and Honors with Exceptional Distinction in Engineering) from Yale University in 1968. Peter and his wife Elsa, have four children and fourteen grandchildren. They reside in Boca Grande, Florida and, during the summer, in Skaneateles, NY.
At Large Board Representative
Ross Donaldson's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
Dr. Donaldson is President & CEO of Critical Innovations LLC, as well as a full Professor of Emergency Medicine at the David Geffen School of Medicine at UCLA. Triple-boarded in emergency medicine, emergency medical services, and clinical informatics, Dr. Donaldson has been principal investigator on over $50 million dollars’ worth of funding, with a focus on research and development efforts bringing innovative emergency, critical, and trauma care technologies to market. He is the inventor of a host of patented medical technologies and the creator of WikEM, the world’s largest and most popular emergency medicine open-access reference resource. Dr. Donaldson has been featured as an expert on CNN, BBC, NPR, and other media outlets, and an invited speaker at over a hundred national and international conferences, including at Medical Design & Manufacturing, Department of Defense, and various think tanks. He has worked around the globe, frequently in areas of conflict and recent disaster, and been the lead architect of national emergency care plans in several countries. For five years in Iraq alone, he led the instruction of over ten-thousand surgeons, physicians, EMTs, nurses, and community members, while spearheading the development of pre-hospital and hospital-based emergency and trauma systems for the country, for which he received the Humanitarian Award from the California chapter of American College of Emergency Physicians. Dr. Donaldson has worked for close to two decades at the Harbor-UCLA Medical Center, one of Los Angeles’ main Level I trauma centers, serving previously as the Director of the Emergency Medicine Global Health Program and Global Health Fellowship. He is also the critically acclaimed author of The Lassa Ward, a memoir about international humanitarian work. Among other honors, he was inaugural recipient of the FOAMed Excellence in Education Award from the Society for Academic Emergency Medicine and has been identified as one of emergency medicine’s key opinion leaders by the Emergency Medicine Residents’ Association.
At Large Board Representative
Michael Brown's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
Michael Brown is the Account Executive and Program Manager of Government Relations for Healthcare R&D at GE HealthCare Technology and Innovation Center formerly General Electric Research (GR). In this role Michael is responsible for developing and executing the strategy that outlines how GRC partners and collaborates with other organizations including academia, industry, government and NGO’s in the healthcare space. The intent of these partnerships is to create innovative technologies that address the current and future healthcare industry needs.
Prior to this role, Michael worked with GE HealthCare as the Enterprise General Manager of Sales, covering strategic academic and commercial accounts in the states of North Carolina, South Carolina and Georgia. Michael has also served as a Business Development Manager at General Electric Research (GR) where he helped to foster successful win-win research collaborations to secure R&D funding from the National Institutes of Health, the Department of Defense (DARPA, US Army, US Navy), BARDA and pharmaceutical companies.
Prior to his 23 year career at General Electric, Michael worked in Marketing and Business Development at Texas Instruments in the Semiconductor and HVAC industries and United Technologies in the Aviation industry.
Michael earned his B.S. in Electrical Engineering from Northeastern University (Boston, MA) and his M.B.A from Rensselaer Polytechnic Institute (Troy, NY)
At Large Board Representative
Mike Black's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
Mike is a strategic business leader with 20 years of executive management, financial, operational and sales/marketing experience in the medical device industry. He is an owner and principal of AccelerMED LLC which provides commercial leadership to emerging medical device companies with novel products that enhance healthcare quality and efficiency. In addition, Mike is on the Board of Visura Technologies and is an advisor to the Band of Angels Life Sciences Special Interest Group.
Mike previously served as Vice President – Global Customer Experience for ZOLL Medical Corporation. ZOLL acquired Advanced Circulatory Systems, Inc. (ACSI) where Mike served as Chief Executive Officer. During his tenure at ACSI, he helped the company grow from the pre-revenue research and development stage to a viable commercial operation. Mr. Black also held positions as CFO and COO at ACSI. Prior to ACSI, Mr. Black spent time in financial and operational roles with early-stage technology companies. He started his career as a financial auditor and consultant for Deloitte.
At Large Board Representative
James Cummings's Bio
Roles & Responsibilities:
At Large Board Representative
Bio:
James F. Cummings, M.D., FACP, FIDSA, FASTMH has served as Chief Medical Officer at Vaxart since August 2021 and is responsible for all clinical vaccine development.. Preceding his role at VAXART, Dr. Cummings served as President of ICON Government and Public Health Solutions, Inc., a global clinical research organization, providing clinical trial and functional services to government and commercial customers, in support of global health. Prior to joining ICON, Dr. Cummings served as Vice President of Clinical Development and Translational Medicine at Novavax, Inc. There he led the development programs for all Emerging and Re-Emerging Infectious Diseases to provide a timely, broad response across the spectrum of emerging infectious diseases. Colonel (Retired) Cummings enjoyed a 26-year career in the U.S. Army with a proven track record in vaccine, drug and diagnostics development, most recently as Director of the Department of Defense (DoD) Global Emerging Infectious Diseases Surveillance and Response Systems (DoD GEIS) leading Biosurveillance for the US DoD with laboratories and partners in 71 countries, along with serving as the Consultant to the Surgeon General for all medical research and development. A graduate of Georgetown University’s School of Medicine, Dr. Cummings trained in Internal Medicine and Infectious Diseases Fellowships at Walter Reed and the National Capital Consortium, is board certified in both disciplines and has been elected to Fellow in the American College of Physicians (FACP), the Infectious Diseases Society of America (FIDSA) and the American Society of Tropical Medicine and Hygiene (FASTMH).
MTEC Leadership
President
Dr. Shawn J. Green's Bio
Roles & Responsibilities:
As President, Shawn reviews our current capabilities, identifies strategic alignment to federal agencies and opportunities, and assists in the capture and execution of said opportunities. He conducts outreach to federal agencies, identifies those that meet strategic alignment and suggests to the President and Board his recommendations. He further uses his network built upon years in the industry to establish relationships that augment MTEC capabilities and provides greater support to government funding sponsors. His small business experience enhances MTEC educational, training, and support offerings to MTEC’s life and health science community and members.
Bio:
Shawn J. Green, PhD is a serial entrepreneur in the life and health sciences. Recently created a number of clinically-supported consumer health nutraceuticals targeting vascular health, including Berkeley Test, Berkeley Life, Vascanox, MyFitStrip. Previously, he served on the founder’s team as Sr. Vice President of R&D at EntreMed (NASDAQ: CASI), a biotechnology company focused on developing anti-angiogenesis strategies for the treatment of cancer with the advancement of thalidomide and thalidomide analogues, currently marketed by Bristol Myers Squibb for the treatment of Multiple Myeloma. Dr. Green also co-founded and served as VP of Research at Maxcyte (NASDQ: MXCT) a clinical-stage medical device company focused on cell-based therapeutics. In partnering with IBM Life Sciences John Wiley & Son, Fujitsu, and Itochu, he founded XML Labook, an online bioinformatics platform to integrate and share targeted data for research scientists. During his early career, Dr. Green served in the Medical Service Corp at Walter Reed and published the first series of papers on the regulation of nitric oxide and its role in innate immunity where he earned the Meritorious Service Medal for his work. He was awarded 20+ patents and published over 100 articles in such journals as, Science, Nature, Nature Medicine, Cancer Research, Journal of Immunology. He served on the editorial board for the American Society of Microbiology and as an editorial reviewer for several biomedical journals. Held academic appointments at Johns Hopkins, Howard, and Catholic and served as a board member for Virginia BIO and as an advisor to Triple Tree, an investment bank in healthcare. Shawn received his Ph.D. in Cellular Biology and MBA from Georgetown University.
Chief Financial Officer
Julia Martin's Bio
Roles & Responsibilities:
Provides leadership over financial management and maintains financial accounting and reporting pays government approved invoices, serves as liaison to federal agencies and external auditors regarding financial reporting requirements, and provides supervision and management of financial operations.
Bio:
Julia Martin is the Chief Financial Officer. She provides financial leadership, serves as liaison for financial reporting to federal agencies, external auditors and company stakeholders, and provides supervision and management of the day-to-day financial operations of SCRA and its affiliated organizations. She directs banking and credit activities, maintains appropriate capital structure to support the companys operations, ensures regulatory compliance and establishes appropriate internal controls for the businesses to manage and reduce risk.
Chief Development Officer
Jill Sorensen's Bio
Roles & Responsibilities:
Provides leadership of MTEC Development work, including oversight of stakeholder relations, foundation relations, industry partners, commercialization, and ventures programs. Building out the MTEC investor network to garner additional dollars and support for MTEC members and medical technologies being developed to advance MTEC’s military medical mission and impact.
Bio:
Jill Sorensen is a senior innovation manager with over 30 years of experience in technology development and commercialization, technology startup investment, intellectual asset portfolio management, fundraising, research and development project management, and oversight of investments in companies developing medical products including biologics, drugs, and devices. She has worked with MRDC and other sponsors in the military medical enterprise, as well as multiple federal agencies including Health and Human Services (HHS) and the life sciences investment community. Jill has worked closely with the for-profit and non-profit sectors in grant and contract management, advancing strategic initiatives, building future interests and coalitions working toward common goals, conducting technology and investment assessments, research project oversight, business practice interfaces, and funding methodologies. Ms. Sorensen is a registered patent attorney in the U.S. and former director of SCRA’s SC Launch, technology commercialization at Johns Hopkins University and the University of Illinois at Chicago.
Chief of Consortium Operations
Kathy Zolman's Bio
Roles & Responsibilities:
Ms. Zolman’s responsibilities as MTEC Chief of Consortium Operations include management of all functions within consortium operations to include OTA execution, membership management, solicitation management, contracting, finance, marketing, and information technology oversight. She has an active role in customer relationships with military funding sponsors and membership.
Bio:
Previously Ms. Zolman was Director of Program Operations for MTEC, where she was an integral part in the growth of the consortium to over 600 members and awarded over $700M of government funding. Ms. Zolman has been instrumental in the startup, business management, day-to-day management, and planning for several collaborative initiatives at Advanced Technology International. She has over 20 years of progressive management experience in program and project management, business development, market research, and financial management. Ms. Zolman earned her undergraduate degree in International Business and Management from Penn State University and holds Spanish Minor from the Universidad de Salamanca, Spain. She has a Masters of International Business Administration from the University of South Carolina.
Chief Science Officer
Dr. Lauren Palestrini's Bio
Roles & Responsibilities:
Coordinates initial market, technology, and funding assessments. Responsible for prioritization of technology objectives and composition of technology product profiles. Will lead all aspects of technology transfer and commercialization operations to ensure the sustainability of MTEC through revenue streams that include royalties from patents generated, venture and/or private equity investments, commercial test agreements and other income sources.
Bio:
Lauren Palestrini, Ph.D., is the Chief Science Officer at MTEC, where she serves as the lead technology officer within the medical product development activities, oversees the development of technology solutions that will meet industry commercialization targets, conducts initial technology assessments, and maintains adequate coverage of military clinical needs. Dr. Palestrini is also working on generating external funding streams through fundraising. Dr. Palestrini earned a Bachelor of Science Degree in Chemical Engineering from Cornell University, and a Doctoral Degree in Biomedical Engineering from Stony Brook University. Her graduate work focused on the development of a biodegradable, electrospun fiber mat for the topical delivery of a novel fibronectin-derived peptide for the limitation of burn injury progression. Until recently, she served as the Director of Research at the New Jersey Center for Biomaterials at Rutgers University where she managed a cross-disciplinary set of research projects in support of the Department of Defense-funded Armed Forces Institute of Regenerative Medicine (AFIRM) cooperative agreement within regenerative medicine. In addition, her prior experience includes process development at Regeneron Pharmaceuticals, research and development at Johnson & Johnson Consumer Products, and human resources at Deutsche Bank.
Chief of Strategy and Business Development
Chris Steele's Bio
Roles and Responsibilities:
The Chief of Strategy and Business Development provides strategic leadership in strengthening current partnerships and developing new opportunities that align with MTEC’s mission of advancing military and public health. This role focuses on expanding MTEC’s customer base and strengthening its financial position. This role strengthens and expands core MTEC capabilities, assesses alignment with new opportunities, and recommends actions to the President and Board. Responsibilities include strategic planning, pursuing federal opportunities, and ensuring initiatives match MTEC’s mission and vision. This role also plays a pivotal part in driving diversity within MTEC, ensuring sustainable growth and long-term stability. The Chief of Strategy and Business Development also represents MTEC in external collaborations, coordinates marketing activities, and assists in executive and board meetings to provide forecasts and strategies for future growth.
Bio:
Christopher Steele serves as the Chief of Strategy and Business Development at the Medical Technology Enterprise Consortium (MTEC), where he leads strategic initiatives to identify and develop new business opportunities that align with MTEC’s mission to advance military and public health. In this role, Steele drives the organization’s efforts to expand its customer base, pursue & partner across federal opportunities, and strengthen MTEC’s financial and reputational standing. His leadership ensures that MTEC remains at the forefront of medical innovation, while building a sustainable and diverse entity.
With over 34 years of service in the Department of Defense (in the US Army and US Navy), Steele held key leadership roles in research and development. He directed the Military Operational Medicine Research Program (MOMRP) for Army and Defense Health Agency funding, and was a Program Officer at the Office of Naval Research. Additionally, he played a pivotal role in joint R&D funding and Navy/Marine Corps prioritization effort at the Navy Bureau of Medicine and Surgery. His experience includes overseeing hundreds of medical research projects (across 9 internal DoD laboratories, external academic and commercial partners) aimed at improving the health, readiness, and performance of Servicemembers. A retired Navy Commander and circadian physiologist, Steele holds a Ph.D. from North Carolina State University and has led numerous military program initiatives, including the Consortium to Alleviate PTSD and the Military Suicide Research Consortium.
Chief Contracting & Compliance Officer
Rebecca Harmon's Bio
Roles & Responsibilities:
As the Chief Contracting/Compliance Officer for MTEC, Rebecca provides leadership and oversight over MTEC contract management. Rebecca’s responsibilities include executing and administering service agreements of behalf of MTEC; ensuring that that MTEC officers, directors and board members understand and are in compliance with the all MTEC Policies; and overseeing the administering, negotiating, and monitoring of all agreements and modifications issued under the MTEC OTA.
Bio:
Rebecca is a Sr. Contracts Manager for Advanced Technology International (ATI). Her responsibilities include negotiating and overseeing prime contracts and subcontracts in ATI’s Medical and Information Management Division. Many of these contracts are complex, involving various government agencies, industries, and universities.
Rebecca has been with ATI over six years. She received a Master’s of Business Administration degree from Charleston Southern University and a Bachelor of Science degree in Marketing from Clemson University. She is a Certified Federal Contracts Manager (CFCM).
Director of Strategic Funding
Dr. Susan Raymond's Bio
Roles & Responsibilities:
Provides leadership for developing external funding streams including fundraising, establishing revolving funds, and grant making strategies for MTEC. Responsible for directing and overseeing all research, cultivation, solicitation and stewardship activities for successfully achieving financial targets required by MTEC research projects from private resource mobilization.
Bio:
Susan Raymond is a founding partner and Executive Vice President of Changing Our World, Inc., an international philanthropy management company. She is responsible for funding and grantmaking strategies for nonprofits, corporate foundations and private high net worth individuals, and has designed new philanthropic mechanisms for clients including Genesis Health System, Health Research, Inc., and the Global Fund for HIV/AIDS, Tuberculosis and Malaria. She holds her Ph.D. in Economics, Policy and Public Health from the Johns Hopkins University. Dr. Raymond is the Director of Strategic Funding for MTEC.
Director of Commercialization
Richard Satcher's Bio
Roles & Responsibilities:
Coordinates initial market, technology, and funding assessments. Responsible for prioritization of technology objectives and composition of technology product profiles. Will lead all aspects of technology transfer and commercialization operations to ensure sustainability of MTEC through revenue streams that include royalties from patents generated, venture and/or private equity investments, commercial test agreements and other income sources.
Bio:
Richard Satcher is a Senior Business Manager with RTI International. He has 20 years of broad experience in strategic planning, business development, technology assessment and commercialization, and project management. He works closely with clients to create partnerships for developing and commercializing health technologies. He has coordinated partnerships for the National Institute of Standards and Technologys Manufacturing Extension Partnership, the Department of Justices Forensic Center of Excellence, NASA, and the Gates Foundation. Ms. Satcher is the Director of Commercialization for MTEC. His roles and responsibilities are to coordinate initial market, technology, and funding assessments.
Treasurer
Bill Evans' Bio
Roles & Responsibilities:
Oversees financial and accounting management for the MTEC entity, and review and approve payment of consortium manager’s invoices. This position must be filled by a person not under the employment of ATI to assure no conflict of interest concerns arising from having one of the consortium manager’s own employees in a position to approve invoices that will be paid to the consortium manager for its financial, contracting, or other services rendered to the MTEC entity.
Bio:
Bill Evans serves as a business consultant and corporate director, following a successful and varied business career. Evans started his professional career in 1971 with Peat Marwick Mitchell & Co., (now KPMG) in Atlanta, GA. He was elected a partner in 1980 and led the firm’s regional technology practice and was one of the founders of the Advanced Technology Development Center at the Georgia Institute of Technology. In 1985, Evans joined Electromagnetic Sciences, Inc. as a Senior Vice President and Director, and helped expand the company’s business from being a $30 million government contractor to a $100 million diversified business three years later. Evans was recruited to Management Sciences of America, Inc. (MSA) in late 1988 to assist with the turnaround of this $250 million independent software vendor. Under his direction, the company returned to profitability and was sold to Dun and Bradstreet (D&B) one year later. In 1992, Evans was recruited by H&R Block, Inc., in Kansas City, Missouri, as Senior Vice President of Corporate Operations. He was actively involved in the extension of Block’s business interests into financial services and the addition of premium tax services and personal tax software to its tax business. Evans joined ProSource, Inc., a privately funded food service distributor based in Miami, Florida, as Chief Financial Officer in 1995. Evans assisted Onex, the Canadian based private equity investor, in completing a roll-up strategy creating a $4 billion company that went public in 1996 and was sold to another foodservice distributor in 1998. During 1998 and 1999, Evans was Chief Financial Officer of Productivity Point International, a roll-up of technology training firms funded by Knowledge Universe, a firm founded by Mike Milken and Larry Ellison. During this formation period, Evans integrated twenty different acquisitions and created a $100 million business. Evans was asked to be President of the troubled electrical wire business unit of Superior Essex, based in Fort Wayne, Indiana, in 1999. He led the restructuring of this $700 million business by selling and consolidating manufacturing and distribution locations, streamlining the product line and sales process, and significantly reducing working capital requirements. Evans joined Witness Systems, a small public software company based in Roswell, GA, in 2002 as Executive Vice President and Chief Financial Officer. Witness Systems grew steadily and profitably over the next 5 years and was sold in 2007 for approximately $1.1 billion.
Evans is currently on the board of Saia, a $1 billion LTL truckload career, where is serves as the Chair of the Audit Committee. He has previously served on the boards of Electromagnetic Sciences, LXE, Spherion, Secureworks, Tatum, ValueVision and WolverineTube. Since 2007, he has also served as an advisor to Technology Operators Fund and a consultant to a variety of businesses, assisting with business restructuring, strategic planning, financing, and other activities.
A native of Chicago, Evans received his BS and MS in Accounting (with Honors) from the University of Illinois in Champaign-Urbana. He currently lives in Johns Creek, GA with his wife, Lacy, and has two daughters and five grandchildren. Evans is a board member of the Imlay Foundation and is active in many local organizations such as The Atlanta Rotary, Special Olympics of Georgia, and Duluth First United Methodist Church.
MTEC Advisors
President Emeritus
William Howell's Bio
Roles & Responsibilities:
Provides leadership to the organization ensuring the military focused mission directs the actions, organization, and functions of the team. He maintains strategic level communications with the military leadership and the board to develop objectives and monitors action plans that support their achievement. He further reaches out to corporate, universities, associations, foundations, and funding partners to bring together a coherent network and means to identify and accelerate technologies that can make a difference in military medicine. His influence reaches far into the medical R&D domain to provide tools and service support for the organization, the consortium members, and the military’s benefit.
Bio:
William Howell is a 35 year DoD retiree who executed senior SES level research project management operations for medical product development in all categories of products including biologics, drugs, and devices. He has worked with and is familiar with the business practices of all DoD medical R&D organizations and several Health and Human Services (HHS) organizations. He has worked closely with industry in conducting technology assessments, CRADA and contract negotiations, research project oversight, business practice interfaces, and funding methodologies. Mr. Howell is the President of MTEC.
MTEC Senior Advisor
Dave Hood's Bio
Bio:
Dave D Hood MS, MBA, PMP serves as a Senior Advisor for the US military medical community’s Medical Technology Enterprise consortium (MTEC). He is also President and CEO of DH3 & Associates, a consulting company focusing on performing technology assessments and developing approaches for product development and business development. Emphasizing the efficient pursuit of non-dilutive funding. Assisted/coached/guided and reviewed hundreds of companies. Helped raise millions of dollars. Expertise and experience with intrapreneurship, entrepreneurship, product development, project/program management, business management and business development. Helping companies work with the government – particularly the military/DOD. Highly regarded as a subject matter expert. Frequent invited speaker at various academic and industry venues domestic and international – US/Canada/Europe/Australia/New Zealand…, AdvaMed/Bio/Medtech Strategist/Life Science Intelligence…. Judge for US Army’s xTechSearch, Judge/reviewer/mentor/panelist for MedTech Innovator, judge for RESI, Principal Advisor and Expert Resource for NIH/LARTA, Senior Advisor for the military medical community’s MTEC, member of the SoCalBio Innovation Catalyst team…
For more than five years, Mr. Hood also served as a Senior Advisor for the Principal Assistant for Acquisitions at the US Army Medical Research and Material Command. Prior to founding DH3 & Associates, Mr Hood was the Co-Founder and President of Integrated Medical Systems where he was also co-inventor of the company’s core product line. Prior to being selected to guide this successful spin-out from Northrop Grumman, he served as a Senior Program Manger successfully guiding the development and deployment of various integrated sensor systems for high performance aircraft, missiles, and satellites including the stealth bomber and the Global Positioning Satellites (GPS). He also guided successful projects pioneering intelligent transportation systems and high performance fuel efficient, environmentally friendly engines and brake systems for automobiles and motorcycles.
Mr. Hood has worked with the US Congress and European governments to sponsor funding for innovative products. He holds 3 patents and has been the stimulus for more than 2 dozen. He has published and presented extensively in the US and Europe. He taught graduate school courses in Project Management, Business Management, Operations Management and Entrepreneurship. He is a certified Project Management Professional and has received executive training from the University of Southern California, the Massachusetts Institute of Technology and Stanford University.
He is also a past Chairman of the Long Beach Sailing Foundation, a 501c organization that owns a fleet of matched sailboats used for team building experiences as well as amateur and professional racing events including the Congressional Cup. The Foundation also provides inner city and disadvantaged teenagers an opportunity to learn the fundamentals of teamwork and sportsmanship. He is also a former board member for the US Sailing Center providing sailing opportunities for disabled children and adults. He is an amateur skipper, 7 Club Championships, 5 National titles, ranked as high as 5th in the US and 37th in the World. Former Commodore of Long Beach Yacht Club.
MTEC Senior Advisor
Stuart Tyner's Bio
Bio:
Colonel (Retired) Stuart Tyner, Ph.D., is a distinguished scientist and leader in the field of infectious diseases research and military medicine. Throughout his 22 year military career, Dr. Tyner served in various leadership positions, including Director of the Defense Health Agency Infectious Diseases Portfolio and Director of the Military Infectious Diseases Research Program. He also served as Chief Science Officer at the US Army Institute of Surgical Research and the Chief of Staff at the Walter Reed Army Institute of Research. In culmination of his service, Dr. Tyner was appointed as the lead policy advisor to the U.S. Army Surgeon General in microbiology. He previously served as the Dept. of Defense’s Ex Officio Member of the NIAID Steering Committee and led the Infectious Diseases Portfolio for the Dept. of Defense’s Biomedical Community of Interest. Dr. Tyner holds an active faculty appointment at USUHS. In addition to his professional achievements, Dr. Tyner is actively engaged in academic and professional activities, serving on multiple editorial boards. Dr. Tyner holds two undergraduate degrees from the University of Notre Dame and a Ph.D. in Cell and Molecular Biology from Baylor College of Medicine. He was a National Cancer Institute Fellow at the National Institutes of Health and completed a Master’s in Strategic Studies at the US Army Senior Service College (Army War College).
MTEC Senior Advisor
Donna Boston's Bio
Bio:
Donna Boston serves as a Senior Advisor for the US military medical community’s Medical Technology Enterprise consortium (MTEC). Ms. Boston led programs for the U.S. Government’s pandemic preparedness and chemical/biological/ radiological/nuclear medical countermeasures (MCM) portfolios, and has a wide breadth of expertise in assessing the technology readiness of developmental products and technologies and their alignment with the needs and interests of USG agencies and investors. She specializes in technical, regulatory and programmatic guidance and can navigate the landscape of strategic opportunities and partnerships, offering a deep knowledge in biotech and health security product development and USG mission requirements. Her background is in chemical engineering (BS, University of Maryland) and biomedical engineering (MS, Johns Hopkins). Following a federal career that spanned three decades, Donna established DSBio Consulting to serve the biomedical entrepreneurial communities of developers, start-ups, and innovators.
MTEC Senior Advisor
George Ludwig's Bio
Bio:
Now retired from Federal service, George V. Ludwig served in the Army Senior Executive Service as the Principal Assistant for Research and Technology at the U.S. Army Medical Research and Development Command (USAMRDC), Army Futures Command, where he exercised scientific oversight and management of the Army and DoD medical Science and Technology programs ($2.1 billion in FY19). These included programs in Military Operational Medicine, Combat Casualty Care, Military Infectious Diseases, Clinical and Rehabilitative Medicine, Medical Simulation and Health Information Technology, Medical Chemical and Biological Defense, and Congressional Directed Special Interest Research Programs. He also had responsibility for oversight and program development of research conducted within the Command’s worldwide system of laboratories, six in the continental United States and three outside the continental United States.
Prior to his most recent position, Dr. Ludwig served as the Civilian Deputy Principal Assistant for Research and Technology for USAMRDC where he was responsible for implementing medical research policy, facilitating strategic partnerships, and coordinating medical research and development intellectual capital and physical infrastructure. He led USAMRMC efforts to establish a new overseas laboratory in Tbilisi, Georgia, He also facilitated and managed efforts to codify and organize USAMRMC scientific and technical competencies.
Dr. Ludwig also served as Acting Director of the Defense Laboratories Office while on temporary assignment to the Assistant Secretary of Defense for Research and Engineering. In that position, Dr. Ludwig served as the primary advocate for the Department’s in-house laboratory system to senior DoD and Service leadership, Congress, academia, and industry. He also had oversight responsibilities for the DoD technology transfer program. He served as the primary source of laboratory policy at the DoD level and developed new legislative initiatives on behalf of the defense laboratories.
Previously Dr. Ludwig served as Science Director at the United States Army Research Institute of Infectious Diseases where he helped USAMRIID meet the challenges of a changing national and international biodefense landscape. Dr. Ludwig also served as Chief of the Diagnostic Systems Division at USAMRIID where he coordinated a program for development of advanced diagnostics capable of identifying potential biological threats and other high-hazard infectious and non-infectious disease agents. Dr. Ludwig worked extensively on vaccine development while at USAMRIID, serving on the team responsible for development of new and innovative vaccine platforms including a recombinant vaccine for Venezuelan Equine Encephalitis, and an alphavirus vaccine replicon capable of stimulating immunity to nearly any disease-causing agent. He traveled extensively in support of humanitarian and capacity-building efforts for the military including as a team leader for disease outbreak investigations in the former Zaire (Ebola virus), Colombia (Venezuelan equine encephalitis virus), and the Southwest United States (Sin Nombre virus). Dr. Ludwig received his Ph.D. from the University of Wisconsin in 1990 and is author of nearly 70 manuscripts, technical reports, book chapters, and other publications written during 30 years of relevant experience. He owns five patents resulting from his work on vaccine delivery systems and has received numerous awards and honors including the Order of Military Medical Merit, Superior Civilian Service Medal and two Achievement Medals for Civilian Service.
MTEC STAFF
Foundation Relations
Kate Golden's Bio
Roles & Responsibilities:
Kate’s responsibilities with MTEC’s Foundation Relations are to grow and enhance relations with philanthropic foundations and nonprofits that engage in research in areas of importance to the military.
Bio:
Ms. Golden has led feasibility studies, worked with and recruited Board members, developed cultivation and solicitation strategies for major gift prospects, written philanthropic grant requests, and developed cases for support as a Senior Managing Director at Changing Our World, a philanthropic services firm headquartered in New York City. She has over twenty years of fundraising experience.
Biomedical Research Associate
Chuck Hutti's Bio
Bio:
Dr. Chuck Hutti, PhD, is the Biomedical Research Associate at MTEC, where he supports the MTEC research operations by working with Military Sponsors on solicitations and conducting outreach to universities and small businesses with relevant solutions. Dr. Hutti earned a Bachelor of Science in Biology at Texas Woman’s University and Doctoral Degree in Cellular, Developmental, and Molecular Biology from the University of Rochester. His graduate work focused on elucidating the role of lysosomes in prion aggregate toxicity and degradation. Prior to his role with MTEC, he worked as a Research Associate at the University of Texas Southwestern focusing on identifying key mechanisms behind breast and ovarian cancer metastasis.
Research Project Analyst
Seth Tomblyn's Bio
Roles & Responsibilities:
Provide technical assessments of funded projects that include analysis of the merit, progress of the Performer as compared to their funded statement of work, determination of the current maturity of the technology, insight into the technology’s competitive landscape, assessment of the Performer’s regulatory strategy, and insight into the technology’s roadmap to transition to the Warfighter and/or the commercial marketplace. The goal is to make recommendations for deeper due diligence by the commercialization team and/or positioning for additional interactions with other funders by the Chief Development Officer.
Bio:
Seth Tomblyn, Ph.D., is a Research Project Analyst at MTEC where he provides technical assessments of MTEC’s funded portfolio. Dr. Tomblyn earned a Bachelor of Science in Chemistry and Biology from Fairmont State University and a Doctoral Degree in Microbiology and Molecular Medicine from Clemson University. His graduate work focused on protein therapies for the treatment of breast cancer. He performed his post-doctoral research at Case Western University Department of Bioengineering where his work focused on tissue engineering applications. Dr. Tomblyn has worked for several small biotechnology companies completing pre-clinical safety and efficacy for medical devices, therapeutics, and cell-based therapies.
Program Manager
Evan Kellinger's Bio
Roles & Responsibilities:
Evan’s responsibilities as MTEC Program Manager includes assisting the Chief of Consortium Operations in the solicitation, implementation and management of the consortium and its members. His specific responsibilities include milestone and deliverable tracking, schedule management and reviewing Statements of Work (SOW).
Bio:
Previously Mr. Kellinger was an Account Representative for a supply and logistics organization. He specifically managed a multi-million dollar portfolio that supported a diverse array of DoD and private sector accounts. Evan has a professional background in Project Management, Capture Management and Business Development. Evan has extensive training in PMI’s project management methodologies and processes. He achieved a Master’s of Science in Project Management (MSPM), a Technical Project Management (TPM) Graduate Certification and a Technical Program Management (TPgM) Graduate Certification from the Citadel.
Communications & Marketing Manager
Madison Bell's Bio
Roles & Responsibilities:
The Marketing Manager at MTEC is responsible for developing and executing comprehensive marketing strategies that enhance the organization’s visibility and engagement with key stakeholders. This role focuses on promoting MTEC’s mission, initiatives, and programs to a diverse audience, including government agencies, industry partners, and the public. The Marketing Manager oversees content creation, digital marketing, social media campaigns, and public relations efforts, ensuring consistent branding and messaging across all platforms.
Key responsibilities include managing the MTEC website and social media presence, driving member engagement through targeted outreach, and collaborating with internal teams to support promotional campaigns for research projects and events. The Marketing Manager also tracks and analyzes marketing performance data, using insights to adjust strategies and optimize engagement. This individual works closely with MTEC leadership to align marketing efforts with the organization’s strategic goals and plays a key role in elevating MTEC’s brand and reputation within the healthcare and research communities.
Bio:
Madison Bell is a dynamic marketing professional with a proven track record in the medical technology sector. Currently serving as the Marketing Manager for the Medical Technology Enterprise Consortium (MTEC), she has played a pivotal role in shaping brand strategies, enhancing communications, and leading marketing initiatives since 2021. Madison is adept at planning and executing MTEC’s presence at multiple industry and government events annually.
With a strong background in communications, Madison crafts core messaging for various platforms, develops executive communications for stakeholders, and coordinates impactful webinars featuring leading organizations in medical technology. Her innovative approach to brand management has resulted in substantial increase in digital traffic.
Prior to her current role, Madison contributed to business development and market research at ATI, where she helped identify funding opportunities and analyzed competitor intelligence.
Connect with her on LinkedIn at linkedin.com/in/madisonbell7 or reach out about marketing opportunities with MTEC at [email protected].
Contracts Manager II
Taylor Hummell's Bio
Roles & Responsibilities:
As the Contracts Administrator for MTEC Taylor manages the daily contractual tasks in accordance with the MTEC Other Transaction Agreement (OTA). Taylor’s responsibilities include administering, negotiating, and monitoring all agreements and modifications issued under the MTEC OTA. Taylor also supports MTEC in the solicitation of project proposals and oversees the cost analysis process.
Contracts Administrator
Mary Kate Knudsen's Bio
Roles & Responsibilities:
Mary Kate is a Sr. Subcontracts Administrator for Advanced Technology International (ATI). Mary Kate has been with ATI for two years. She assists in negotiating, monitoring and administering contracts and subcontracts from pre-award through closeout.
Sr. Subcontracts Administrator
Charlotte Getsey's Bio
Roles & Responsibilities:
Charlotte is a Sr. Subcontracts Administrator at Advanced Technology International (ATI). She assists in the cost analysis, administration, negotiation, and monitoring of agreements and modifications.
Bio:
Charlotte has been with ATI for two years. She received a Bachelor of Science degree in Business Administration from the College of Charleston.
Subcontracts Administrator II
Sarah Teuscher's Bio
Roles & Responsibilities:
As a Subcontracts Administrator I for MTEC, Sarah serves as a key member of the contracts team. Sarah’s responsibilities include preparing requests for proposals, various types of subcontract agreements, teaming agreements, amendments, and other funding documents; maintaining contractual records in accordance with the MTEC Other Transaction Agreement (OTA); and assisting members with solicitations and the cost analysis process.
Bio:
Sarah began her career at ATI in March 2023 and has provided contractual support across several consortiums. Prior to joining ATI, Sarah experienced a diverse range of employment within the automotive, financial services and performing arts industries. Sarah graduated from James Madison University with a Bachelor of Music in Music Industry and Louisiana State University with a Master’s in Music Performance.
Subcontracts Administrator II
Brittany Nunnally's Bio
Roles & Responsibilities:
Brittany is a Subcontracts Administrator II at Advanced Technology International (ATI). She assists with cost analysis, administration, and monitoring of agreements from pre-award through closeout.
Bio:
Brittany began her career with ATI in August of 2022 and is providing contractual support for MTEC. Prior to joining ATI she was employed with law enforcement supporting their records division. Brittany graduated from Illinois State University with a Bachelor of Science degree, majoring in Business Administration. Brittany has a strong passion for customer service and teamwork.
Subcontracts Administrator
Kasandra Kloc's Bio
Roles & Responsibilities:
As a Subcontracts Administrator I for MTEC, Kasandra serves as a key member of the contracts team. Kasandra’s responsibilities include preparing requests for proposals, various types of subcontract agreements, teaming agreements, amendments, and other funding documents; maintaining contractual records in accordance with the MTEC Other Transaction Agreement (OTA); and assisting members with solicitations and the cost analysis process.
Bio:
Kasandra began her career at ATI in October 2023 and is providing contractual support for MTEC. She has recently graduated from the College of Charleston with a Bachelors in Science for Business Administration and an Associates degree in Sustainability and Leadership.
Executive Assistant
Elizabeth Barton's Bio
Roles & Responsibilities:
Elizabeth’s responsibilities as MTEC Executive Assistant include interfacing with MTEC board members and leadership, meeting facilitation, SharePoint administration, etc.
Bio:
Elizabeth has been with ATI since 2008. She has worked in various capacities for the Naval Technologies Division prior to joining the Accounting and Finance Department in 2021, including program administration for the Center for Naval Management, a Navy ManTech Center of Excellence. She has enjoyed being involved in numerous programs and initiatives at ATI over the years. Prior to ATI, she worked as a research assistant and budgeting technician for Charleston County School District. She is a native to the Charleston area.
Sr. Accounting Manager
Heather Benson's Bio
Roles & Responsibilities:
Heather’s responsibilities as MTEC Accounting Manager include managing the accounting functions, review of daily transactions, A/P, billing & A/R, general ledger entries, monthly closing, bank reconciliations and cash reporting, tax compliance and reporting, compliance monitoring, and audit interface
Bio:
Heather has worked in the government contracting industry since 2005 ranging from homeland security to aerospace to nuclear remediation, supporting DoD, DOE, and commercial customers. She has served as a key member of the Costpoint implementation team at two employers, both transitioning from GCS Premier to Costpoint. She spearheaded the implementation of a more robust payroll software solution when conversion was necessary due to rapid growth. She also implemented a training program for Program Management to use the tools needed to help manage projects and track costs more accurately.
Sr. Financial Analyst
Jena Garrett's Bio
Roles & Responsibilities:
Provides financial management and analysis for MTEC’s Consortium Management Firm, tracks program monthly expenditures and forecasts, and assists with MTEC’s annual budget. Collaborates with MTEC Entity Financial Analyst and MTEC Accounting Manager to analyze and track MTEC financial performance.
Bio:
Ms. Garrett is a Sr. Financial Analyst for Advanced Technology International (ATI). Her responsibilities include development, oversight and analysis of financial data for ATI’s Medical and Information Management Division (MIM) division. In this capacity she is primarily responsible for the development of the division annual operating plan, tracking and forecasting program monthly financial results and expenditures, interpretation and analysis of financial performance, and reporting on program and division financial health.
Ms. Garrett has over twenty years’ experience in financial management and analysis. She is a graduate of Winthrop College with a Bachelor of Science degree in Business Administration, and certified as a Project Management Professional (PMP) with the Project Management Institute in 2004.
Entity Financial Analyst
Paul Maschek's Bio
Roles & Responsibilities:
Paul’s responsibilities as MTEC Entity Financial Analyst include collaborating and reconciling MTEC’s monthly financial snapshot with the MTEC Accounting Manager and MTEC’s Consortium Management Firm. Paul also prepares a monthly financial package for the MTEC officers, tracks cash flow forecasts, reviews budget to actual expenditures, and assists with MTEC’s annual budget.
Bio:
Paul works for ATI as a Financial Analyst assisting program specific needs as well as supporting ATI corporate FP&A requests. Paul enjoys working with excel and using it to analyze financial performance and operational metrics.